Trial Profile
An open-label, single-center, randomized phase 1 trial to compare pharmacokinetic parameters of ruxolitinib sustained release with ruxolitinib immediate release in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary) ; Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Pharmacokinetics
- 04 Dec 2018 New trial record